AMD’s Mark Papermaster confirms Radeon Instinct MI100 accelerator

Published: 17th Jun 2020, 15:59 GMT   Comments

AMD’s CTO Mark Papermaster has confirmed the MI100 accelerator coming 2H 2020.

AMD Radeon Instinct MI100

The first CDNA-based Radeon Instinct will arrive in the second half of 2020, AMD’s Mark Papermaster today confirmed.

The MI100 is likely to succeed MI60 accelerator, which is equipped with a Vega 20 graphics processor. The MI100 is rumored to feature Arcturus GPU with an undisclosed number of Stream Processors. The processor is likely to feature 7nm CDNA 1x architecture.

At the same time as NVIDIA introduced its streamlined Ampere architecture, which will be used for both gaming and data-center products, AMD announced that future Radeon products will be built either using rDNA architecture for gaming or CDNA for data-centers.

Mark Papermaster confirmed the MI100 discrete GPU accelerator coming in the second half of 2020 during Dell’s EMC High-Performance Computing Online event.

Source: Wccftech, Hassan Mujtaba, DellHPC




Comment Policy
  • Comments must be written in English.
  • Comments deemed to be spam or solely promotional in nature will be deleted. Including a link to relevant content is permitted, but comments should be relevant to the post topic.
  • Comments containing language or concepts that could be deemed offensive will be deleted. Note this may include abusive, threatening, pornographic, offensive, misleading or libelous language.
  • A failure to comply with these rules will result in a warning and, in extreme cases, a ban.
  • Please note that comments that attack or harass an individual directly will be deleted and such comments will result in a ban.
  • VideoCardz Moderating Team reserves the right to edit or delete any comments submitted to the site without notice.
  • If you would like to appeal for a comment section ban to be removed, please use this page.
  • If you have any questions about the commenting policy, please let us know through the Contact Page.
Hide Comment Policy
Comments